Results 131 to 140 of about 34,973 (226)

Activation and modulation of cardiac poly-adenosine diphosphate ribose polymerase activity in a rat model of brain death

DNA damage during transplantation can activate poly-adenosine diphosphate ribose polymerase (PARP) resulting in the generation of polymers of adenosine diphosphate-ribose (PAR).
Brain JG, Rostron AJ, Kirby JA, Dark JH
core  

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

OXOVANADIUM(IV) COMPLEXATION BY ADENOSINE 5'-DI-PHOSPHATE AND 5'-TRI-PHOSPHATE AND NUCLEOTIDE BUILDING-BLOCKS

, 1995
Complex formation between oxovanadium(IV) and the bioligands adenosine 5'-diphosphate (ADP), adenosine 5'-triphosphate (ATP), adenine, adenosine and 2'-deoxyadenosine 5'-diphosphate (dADP) was investigated in aqueous solution by EPR, electronic ...
DEWAELE D, ALBERICO E, KISS T, MICERA, Giovanni   +3 more
core   +1 more source

Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D

, 2007
Vitamin D is well characterized for its role in mineral homeostasis and maintenance of normal skeletal architecture. Vitamin D has been demonstrated to exert anti-inflammatory effects in a variety of disease states including diabetes, arthritis and ...
Szabo, C., Mabley, Jon; id_orcid, Wallace, R., Pacher, P., Murphy, K.   +4 more
core  

Occurrence of Pancytopenia Among Patients With Cancer Treated With Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitors: A Pharmacoepidemiologic Study.

JAMA Oncol, 2021
Morice PM, Chrétien B, Da Silva A, Dolladille C, Alexandre J.   +4 more
europepmc   +1 more source

The status of poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors in ovarian cancer, part 2: extending the scope beyond olaparib and BRCA1/2 mutations [PDF]

, 2016
Poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors have shown clinical activity in epithelial ovarian cancer, leading both the US Food and Drug Administration (FDA) and the European Medicines Agency to approve olaparib for tumors ...
Miller, RE, Ledermann, JA
core  

Model for Predicting Serious Hematological Adverse Events in Individuals With Ovarian Cancer Receiving Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Treatment: Prospective Cohort Study. [PDF]

JMIR Med Inform
Lian X, Lei Y.
europepmc   +1 more source

Poly(Adenosine Diphosphate Ribose) Polymerase (PARP) Inhibitors in the Treatment of Advanced Ovarian Cancer: A Narrative Review. [PDF]

Cureus
Dewani D, Jaiswal A, Karwade P.
europepmc   +1 more source

Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted ¹⁸F-Fluorthanatrace PET in Breast Cancer. [PDF]

J Nucl Med
Young AJ, Pantel AR, Kiani M, Doot RK, Bagheri S, Pryma DA, Farwell MD, Li S, Lee H, Schubert EK, Secreto A, Zuckerman SP, Nayak A, Choi H, Carlin S, DeMichele A, Mankoff DA, Zhou R, Mach RH, McDonald ES.   +19 more
europepmc   +1 more source

Studies on Poly Adenosine Diphosphate-Ribose

Journal of Biological Chemistry, 1969
Teruo Shima, Shinji Fujimura, Shuji Hasegawa, Yoshiko Shimizu, Takashi Sugimura   +4 more
openaire   +1 more source